Day: January 6, 2022

HOUSTON, Jan. 06, 2022 (GLOBE NEWSWIRE) — Occidental (NYSE:OXY) will announce its fourth quarter 2021 financial results after close of market on Thursday, February 24, 2022, and will hold a conference call to discuss results on Friday, February 25, 2022, at 1 p.m. Eastern/12 p.m. Central. The conference call may be accessed by calling 1-866-871-6512 (international callers dial 1-412-317-5417) or via webcast at oxy.com/investors. Participants may pre-register for the conference call at https://dpregister.com/sreg/10162667/f0506288be. Fourth quarter 2021 financial results will be available through the Investor Relations section of the company’s website. A recording of the webcast will be posted on the website within several hours after the call is completed. About Occidental Occidental is an international energy company with assets...

Topline data expected in second half of 2022 VALENCIA, Calif. and MELBOURNE, Australia, Jan. 06, 2022 (GLOBE NEWSWIRE) — AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that it has completed enrollment into its pivotal trial for the use of the RECELL® System for soft-tissue reconstruction. Currently, the RECELL System is indicated in the U.S. for treatment of acute thermal burns. Topline data will be shared later this year. “Completing enrollment of the pivotal trial assessing use of the RECELL® System for treatment of soft-tissue reconstruction is an important milestone for AVITA Medical and moreover, is synergistic with our current commercial...

NOVATO, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced that Emil D. Kakkis, M.D., Ph.D., the company’s Chief Executive Officer and President, will present at the H.C. Wainwright BioConnect Conference on Thursday, January 13, 2022 at 7:00 AM ET. The live and archived webcast of the presentation will be accessible from the company’s website at http://ir.ultragenyx.com/events.cfm. The replay of the webcast will be available for 90 days. About Ultragenyx Pharmaceutical Inc. Ultragenyx is a biopharmaceutical company committed to bringing novel products to patients for the treatment of serious rare and ultra-rare genetic diseases....

DALLAS, Jan. 06, 2022 (GLOBE NEWSWIRE) — Capital Southwest Corporation (“Capital Southwest”) (Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, announced today that it backed Culper Capital Partners’ (“Culper”) investment in The Producto Group (“Producto” or the “Company”) with a senior secured first lien term loan and a minority investment in the common equity. The Producto Group is formed by the acquisition of Ring Precision Components, New Vision Industries, and Dieco. Capital Southwest led the financing and will act as the sole administrative agent on the facility. “We are thrilled to partner with Culper on the formation of its first operating platform, Producto. We look forward to supporting...

Raises More Than $1 Million Through Donations for The Leukemia & Lymphoma Society Commits Over $1 Million to Charitable Efforts, Including Disaster Relief and Supporting Veterans DALLAS, Jan. 06, 2022 (GLOBE NEWSWIRE) — Builders FirstSource, Inc. (NYSE: BLDR) (“Builders FirstSource” or the “Company”), the nation’s premier supplier of building materials and services, today announced it raised more than $1 million for The Leukemia & Lymphoma Society (“LLS”) in 2021. The Company also announced it has committed to contribute more than $1 million to select non-profit organizations focused on emergency relief, disaster assistance and serving veterans and their families. Builders FirstSource’s contribution to LLS aids the organization’s mission to cure leukemia, lymphoma, Hodgkin’s disease and myeloma...

RICHMOND, Va., Jan. 06, 2022 (GLOBE NEWSWIRE) — Bowlero Corp. (NYSE: BOWL) (“Bowlero”) today announced that Brett Parker, President and Chief Financial Officer of Bowlero, will participate in a fireside chat hosted by Nicole Miller Regan, Managing Director at Piper Sandler, at the ICR Virtual Conference 2022. The discussion will take place on Tuesday, January 11, 2022 at 10:30 AM ET. Participants may access a live webcast of the fireside chat on the Bowlero Investor Relations website at https://ir.bowlerocorp.com/overview/default.aspx. If you would like to schedule a meeting with management please contact Ryan.Lawrence@icrinc.com. About Bowlero Corp.Bowlero Corp. is the worldwide leader in bowling entertainment, media, and events. With more than 300 bowling centers across North America, Bowlero Corp. serves more than 26 million...